Brief: Gbs Inc Announces Its Pre-Submission Package Is With The FDA

Intelligent Bio Solutions

13/10/2021 14:39

Oct 13 (Reuters) - Gbs Inc  GBS.O :
    * GBS INC. ANNOUNCES ITS PRE-SUBMISSION PACKAGE IS WITH THE
FDA
    * GBS-PROPOSED 3 STEP CLINICAL PLAN INVOLVES GENERATION OF
PROSPECTIVE DATA,TO EXPLORE RELATIONSHIP BETWEEN SALIVARY
GLUCOSE AND PLASMA GLUCOSE
    * GBS-NEXT PHASE DEVELOPMENT OF ALGORITHM BETWEEN PLASMA AND
SALIVARY GLUCOSE,FINAL STAGE CONFIRM ALGORITHM,GENERATE DATA FOR
REGULATORY SUBMISSION
    * GBS-FOR FIRST PHASE INTENDS TO RECRUIT 20-40 SUBJECTS, IS
CURRENTLY FINALIZING ARRANGEMENTS WITH US BASED CLINICAL
RESEARCH SITES
    * GBS - DEVELOPING A SALIVA BASED GLUCOSE TEST ON BIOSENSOR
PLATFORM TO BE USED IN POINT-OF-CARE SETTING
    * GBS - INTENDS TO PROVIDE PEOPLE LIVING WITH DIABETES A
MORE
FAVORABLE SOLUTION TO FINGER-PRICK BLOOD GLUCOSE TESTING

Source text for Eikon:  ID:nGNX3kjzZt 
Further company coverage:  GBS.O